About the Summit
The Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.
2015 Concurrent Programs
• Enabling Point-of-Care Diagnostics
• Predictive Cancer Biomarkers
• Companion Diagnostics
• Coverage and Reimbursement of Advanced Diagnostics
• Clinical NGS Assays
• Molecular Diagnostics for Infectious Disease
• Clinical Application of Cell-Free DNA
• Diagnostics to Guide Cancer Immunotherapy
• Commercialization of Molecular Diagnostics
• Leveraging Pharmacies for Rapid Diagnostics
• NGS Diagnostics
"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences
"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline
"As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic
"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH
View More Attendee Quotes